Mid-Year Report

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$2,300,000

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Educate members of Congress, USTR, Commerce, State on compulsory licenses in Thailand and Brazil (no specific legislation). Support intellectual property protections in trade negotiations. (Peru FTS, Panama FTA, Coumbia FTA, Korea FTA).

LobbyistCovered position, as disclosed
VICTORIA BLATTER N/A
TOM BOMBELLES N/A
ANNE ESPOSITO N/A
JANE HORVATH N/A
LAURIE MICHEL N/A
PETER RUBIN N/A
JASON BENJAMIN VAN PELT N/A

Contacted: SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

Support amendments to Patent reform legislation concerning post-grant review authority, apportionment of damages and inequitable conduct provisions (S. 1145, H.R. 1908).

LobbyistCovered position, as disclosed
VICTORIA BLATTER N/A
TOM BOMBELLES N/A
ANNE ESPOSITO N/A
JANE HORVATH N/A
LAURIE MICHEL N/A
PETER RUBIN N/A
JASON BENJAMIN VAN PELT N/A

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Budget/Appropriations BUD

Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 2008 Labor-HHS Appropriations bills) Support increased funding for FDA (FY 2008 Agriculture Appropriations bills).

LobbyistCovered position, as disclosed
VICTORIA BLATTER N/A
TOM BOMBELLES N/A
ANNE ESPOSITO N/A
JANE HORVATH N/A
LAURIE MICHEL N/A
PETER RUBIN N/A
JASON BENJAMIN VAN PELT N/A

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC)

Health Issues HCR

Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).

LobbyistCovered position, as disclosed
VICTORIA BLATTER N/A
TOM BOMBELLES N/A
ANNE ESPOSITO N/A
JANE HORVATH N/A
LAURIE MICHEL N/A
PETER RUBIN N/A
JASON BENJAMIN VAN PELT N/A

Contacted: State, Dept of (DOS); SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2900 (110th), S. 1080 (110th)

Medicare/Medicaid MMM

Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).

LobbyistCovered position, as disclosed
VICTORIA BLATTER N/A
TOM BOMBELLES N/A
ANNE ESPOSITO N/A
JANE HORVATH N/A
LAURIE MICHEL N/A
PETER RUBIN N/A
JASON BENJAMIN VAN PELT N/A

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR); State, Dept of (DOS)

Bills named: H.R. 4 (110th), S. 250 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.